90/019,776B-VITAMIN AND AMINO ACID CONJUGATES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, DERIVATIVES THEREOF, AND METHODS OF PREPARATION THEREOF10,000,520Open
Status
Reexamination forwarded to Board for Decision on Appeal
Requester (Patent Owner)Inferred
Requested By
Patent Owner
P.O. Law Firm
Reexam History (44 events)
Aug 26, 2026RXBPAIReexam Forwarded to PTAB
Jun 22, 2026RXAPRBReply Brief Filed
Apr 21, 2026MRAEARX - Mail Examiners Answer
Mar 27, 2026RXAPBRAppeal Brief Review Complete
Mar 27, 2026RXAP.BAppeal Brief Filed
Jan 29, 2026MRADVRX - Mail Reexam - Advisory Action (or Supplemental)
Jan 28, 2026RXN/APNotice of Appeal Filed
Jan 23, 2026RXAAF.Response to Final Filed (or Ready for Examiner Action)
Dec 19, 2025M844Information Disclosure Statement (IDS) Filed
Dec 10, 2025MREXNRX - Mail Examiner Interview Summary Record
Nov 24, 2025RXLET.Miscellaneous Incoming Letter
Nov 10, 2025MRADVRX - Mail Reexam - Advisory Action (or Supplemental)
Nov 3, 2025IDSCInformation Disclosure Statement considered
Oct 29, 2025WIDSInformation Disclosure Statement (IDS) Filed
Oct 29, 2025RXAAF.Response to Final Filed (or Ready for Examiner Action)
Aug 29, 2025MRXFRRX - Mail Final Rejection
Aug 11, 2025RXA...Response after Non-Final Action
Jun 9, 2025MR.NFRX - Mail Reexam Non-Final Action
May 6, 2025RXFWDXDate Forwarded to Examiner
Jan 16, 2025MREXORX - Mail Ex Parte Request for Reexamination Granted
Jan 6, 2025IDSCInformation Disclosure Statement considered
Dec 23, 2024MRPWPRX - Mail Pilot Waiver Program - Ex Parte Interview Summary
Dec 19, 2024DOCKCase Docketed to Examiner in GAU
Dec 18, 2024MRXNReexamination Formalities Notice Mailed
Dec 18, 2024MRXNReexamination Formalities Notice Mailed
Dec 18, 2024COMPApplication Is Now Complete
Dec 17, 2024SMALApplicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27
Dec 17, 2024RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Dec 17, 2024RXNREQFDNotice of reexamination request filing date
Dec 17, 2024RXNREQAUNotice of assignment of reexamination request
Dec 17, 2024FTFSFITF set to YES - revise initial setting
Dec 16, 2024RXTTLRPTTitle Report
Dec 13, 2024WIDSInformation Disclosure Statement (IDS) Filed
Dec 13, 2024WIDSInformation Disclosure Statement (IDS) Filed
Dec 13, 2024WIDSInformation Disclosure Statement (IDS) Filed
Dec 13, 2024WIDSInformation Disclosure Statement (IDS) Filed
Dec 13, 2024WIDSInformation Disclosure Statement (IDS) Filed
Dec 13, 2024RXOSUBReceipt of Original Ex Parte Reexam Request
Dec 13, 2024RXO_40Receipt of Orig. Ex Parte Reexam Request Less Than 40 Pages-Rule 1.20(c )(1)
Dec 13, 2024RXLITSRReexam Litigation Search Conducted
Dec 13, 2024RXIDS.RReexam - Information Disclosure Statement Filed by Third Party Requester
Dec 13, 2024RXC/SRCertificate of Service
Dec 13, 2024PRXRParalegal Reexam Review Complete
Dec 13, 2024BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)
Prosecution, PTAB & CAFC
PTAB Proceedings (IPR, PGR, CBM, DER)
None found
Federal Circuit (CAFC)
None found
Terminal Disclaimer
None found
Prosecution History
None found
Maintenance Fees
Grant
Jun 19, 2018
3.5-yr
Dec 19, 2021
Paid Jul 28, 2021
7.5-yr
Dec 19, 2025
Paid Jul 8, 2025
11.5-yr
Dec 19, 2029
Expiry
Mar 16, 2037
Entity Status
Small Entity
Expires
Mar 16, 2037 (11 yr remaining)
Assignments
AssignmentReel/Frame: 042187/0026Recorded: Apr 28, 2017
From
KERRI CROSSEYInventor
Mar 22, 2016
RICHARD CUNNINGHAMInventor
Mar 22, 2016
RYAN DELLINGERInventor
Apr 27, 2016
DR. MARIE MIGAUDInventor
Aug 25, 2016
BRIAN NETTLESInventor
May 3, 2016
PHILIP REDPATHInventor
Jan 9, 2016
TROY RHONEMUSInventor
Apr 27, 2016
SYLESH VENKATARAMANInventor
Apr 27, 2016
→
To
CHROMADEX, INC.